Cenobamate News

← Back to News Overview


Cenobamate currently has 0 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Cenobamate with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
  • Original indication: Adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at...
  • Evidence level: L5
  • Predicted indications (20):
    • partial epilepsy (98.3%)
    • guanidinoacetate methyltransferase deficiency (97.8%)
    • status epilepticus (97.5%)
    • visual epilepsy (97.1%)
    • beta-ketothiolase deficiency (97.1%)
    • Rett syndrome, congenital variant (96.1%)
    • 14q12 microdeletion syndrome (96.0%)
    • startle epilepsy (95.9%)
    • eating seizures (95.9%)
    • thinking seizures (95.9%)
    • orgasm-induced seizures (95.9%)
    • micturation-induced seizures (95.9%)
    • audiogenic seizures (95.9%)
    • adolescent/adult onset autosomal dominant epilepsy with auditory features (95.6%)
    • reading seizures (94.9%)
    • epilepsy with generalized tonic-clonic seizures (94.2%)
    • partial motor epilepsy (93.4%)
    • trigeminal nerve neoplasm (91.2%)
    • epilepsy (90.7%)
    • restless legs syndrome (87.2%)

View full drug report →

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.

Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.